study evaluating oil control benefit from using a face wash
- Registration Number
- CTRI/2023/06/053661
- Lead Sponsor
- Himalaya Wellness Company
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 80
For Group 1:
1. Sufficient number of male subjects will be enrolled and 40 are required to complete the study.
2. Male adult subjects in general good health as determined from a recent medical history.
For Group 2:
1. Sufficient number of male and female subjects (1:3) will be enrolled and 40 are required to complete the study.
2. Male and female adult subjects in general good health as determined from a recent medical history.
Common for both group:
1. Subjects with oily skin with sebum =130
2. Subjects should refrain from washing their face for 12 hrs prior to test product application.
3. Subject free of excessive hair, acne, cuts, abrasions, fissures, wounds, lacerations, or any other active skin conditions on the face.
4. Subject to agree to remove all jewellery etc. during assessments.
5. Subjects willing to give a voluntary written informed consent and agree to come for regular follow up.
6. Subjects willing to abide by and comply with the study protocol.
7. Subjects who have not participated in a similar investigation in past four weeks.
8. Subjects who are willing not to participate in any other clinical study during participation in the current study.
1. Subject with any other signs of significant local irritation or skin disease.
2. Subject currently taking any medication, which the investigator believes may influence the interpretation of the data.
3.Subject having chronic illness or had major surgery in the last year.
4.Subjects undergoing any treatment of any skin condition.
5. Subjects not willing to discontinue other topical skin care products until completion of the study.
6. Subject allergic or sensitive to bar cleansing products, creams/lotions, artificial jewellery or anything else.
7. Subjects with any underlying uncontrolled medical illness including diabetes mellitus, hypertension, liver disease or history of alcoholism, HIV, hepatitis, or any other serious medical illness.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method